Lexology May 24, 2024
Quest Diagnostics recently announced a multi-faceted collaboration with PathAI to improve diagnoses in cancer and other diseases using AI pathology innovations.
Under a first agreement, Quest will acquire some of the assets of PathAI Diagnostics that provide anatomic and digital pathology laboratory services. This will support Quest’s specialty pathology businesses. Under a second agreement, Quest will license PathAI’s digital pathology management system, AISight™.
Regarding the collaboration, Kristie Dolan, Quest’s Senior Vice...
Today's Sponsors
Today's Sponsor